Healthcare provider profile · identity verified

Walter Harry Culver, M.D.

Internal Medicine · ROCHESTER HILLS, MI · NPI 1346240918

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	309	32
Atorvastatin Calcium	Atorvastatin Calcium	264	81
Alprazolam	Alprazolam	238	39
Amlodipine Besylate	Amlodipine Besylate	176	49
Simvastatin	Simvastatin	171	43
Levothyroxine Sodium	Levothyroxine Sodium	162	48
Omeprazole	Omeprazole	156	45
Lisinopril	Lisinopril	152	42
Metformin Hcl	Metformin Hcl	136	45
Gabapentin	Gabapentin	116	21
Hydrochlorothiazide	Hydrochlorothiazide	111	31
Losartan Potassium	Losartan Potassium	102	30
Rosuvastatin Calcium	Rosuvastatin Calcium	98	32
Acetaminophen-Codeine	Acetaminophen With Codeine	95	suppressed
Metoprolol Succinate	Metoprolol Succinate	94	26
Furosemide	Furosemide	89	26
Albuterol Sulfate Hfa	Albuterol Sulfate	80	32
Oxycodone Hcl	Oxycodone Hcl	79	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	74	20
Clopidogrel	Clopidogrel Bisulfate	68	22
Prednisone	Prednisone	64	41
Diazepam	Diazepam	60	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	59	14
Celecoxib	Celecoxib	57	14
Famotidine	Famotidine	54	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Tamsulosin Hcl	Tamsulosin Hcl	51	20
Eliquis	Apixaban	49	14
Pantoprazole Sodium	Pantoprazole Sodium	48	21
Tramadol Hcl	Tramadol Hcl	48	suppressed
Ondansetron Odt	Ondansetron	47	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	11
Pregabalin	Pregabalin	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	43	14
Fluticasone Propionate	Fluticasone Propionate	42	21
Meloxicam	Meloxicam	42	13
Trazodone Hcl	Trazodone Hcl	42	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	13
Lorazepam	Lorazepam	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	30
Jardiance	Empagliflozin	40	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	35
Ibuprofen	Ibuprofen	39	16
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Allopurinol	Allopurinol	38	11
Carvedilol	Carvedilol	38	suppressed
Atenolol	Atenolol	36	11
Meclizine Hcl	Meclizine Hcl	36	12
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Glimepiride	Glimepiride	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Methocarbamol	Methocarbamol	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	28	suppressed
Carisoprodol	Carisoprodol	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Finasteride	Finasteride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Amoxicillin	Amoxicillin	21	19
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	14
Ramipril	Ramipril	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Estradiol	Estradiol	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Valsartan	Valsartan	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Tobramycin	Tobramycin	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Glipizide	Glipizide	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Azithromycin	Azithromycin	13	13
Cefdinir	Cefdinir	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error